ロード中...
Predictors of orphan drug approval in the European Union
OBJECTIVE: To encourage the development of drugs for rare diseases, orphan drug legislation has been introduced in the USA (1983) and in the EU (2000). Recent literature discusses factors that may influence the development of new orphan medicinal products in the EU. This study aims to identify predi...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2668549/ https://ncbi.nlm.nih.gov/pubmed/18210097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-007-0454-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|